Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080920152> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- W2080920152 endingPage "499" @default.
- W2080920152 startingPage "488" @default.
- W2080920152 abstract "Background: Lithium carbonate and valproate semisodium are both recommended as monotherapy for prevention of relapse in bipolar disorder, but are not individually fully effective in many patients. If combination therapy with both agents is better than monotherapy, many relapses and consequent disability could be avoided. We aimed to establish whether lithium plus valproate was better than monotherapy with either drug alone for relapse prevention in bipolar I disorder. Methods: 330 patients aged 16 years and older with bipolar I disorder from 41 sites in the UK, France, USA, and Italy were randomly allocated to open-label lithium monotherapy (plasma concentration 0.4–1.0 mmol/L, n=110), valproate monotherapy (750–1250 mg, n=110), or both agents in combination (n=110), after an active run-in of 4–8 weeks on the combination. Randomisation was by computer program, and investigators and participants were informed of treatment allocation. All outcome events were considered by the trial management team, who were masked to treatment assignment. Participants were followed up for up to 24 months. The primary outcome was initiation of new intervention for an emergent mood episode, which was compared between groups by Cox regression. Analysis was by intention to treat. This study is registered, number ISRCTN 55261332. Findings: 59 (54%) of 110 people in the combination therapy group, 65 (59%) of 110 in the lithium group, and 76 (69%) of 110 in the valproate group had a primary outcome event during follow-up. Hazard ratios for the primary outcome were 0.59 (95% CI 0.42–0.83, p=0.0023) for combination therapy versus valproate, 0.82 (0.58–1.17, p=0.27) for combination therapy versus lithium, and 0.71 (0.51–1.00, p=0.0472) for lithium versus valproate. 16 participants had serious adverse events after randomisation: seven receiving valproate monotherapy (three deaths); five lithium monotherapy (two deaths); and four combination therapy (one death). Interpretation: For people with bipolar I disorder, for whom long-term therapy is clinically indicated, both combination therapy with lithium plus valproate and lithium monotherapy are more likely to prevent relapse than is valproate monotherapy. This benefit seems to be irrespective of baseline severity of illness and is maintained for up to 2 years. BALANCE could neither reliably confirm nor refute a benefit of combination therapy compared with lithium monotherapy. Funding: Stanley Medical Research Institute; Sanofi-Aventis. (Reprinted with permission from Lancet 2010; 375:385–395)" @default.
- W2080920152 created "2016-06-24" @default.
- W2080920152 creator A5007077090 @default.
- W2080920152 creator A5037628078 @default.
- W2080920152 creator A5051815364 @default.
- W2080920152 creator A5052894205 @default.
- W2080920152 creator A5060367150 @default.
- W2080920152 creator A5066706117 @default.
- W2080920152 creator A5074939684 @default.
- W2080920152 creator A5083356818 @default.
- W2080920152 creator A5090027737 @default.
- W2080920152 date "2011-01-01" @default.
- W2080920152 modified "2023-10-14" @default.
- W2080920152 title "Lithium Plus Valproate Combination Therapy Versus Monotherapy for Relapse Prevention in Bipolar I Disorder (BALANCE): A Randomised Open-Label Trial" @default.
- W2080920152 doi "https://doi.org/10.1176/foc.9.4.foc488" @default.
- W2080920152 hasPublicationYear "2011" @default.
- W2080920152 type Work @default.
- W2080920152 sameAs 2080920152 @default.
- W2080920152 citedByCount "7" @default.
- W2080920152 countsByYear W20809201522014 @default.
- W2080920152 countsByYear W20809201522018 @default.
- W2080920152 countsByYear W20809201522020 @default.
- W2080920152 countsByYear W20809201522022 @default.
- W2080920152 crossrefType "journal-article" @default.
- W2080920152 hasAuthorship W2080920152A5007077090 @default.
- W2080920152 hasAuthorship W2080920152A5037628078 @default.
- W2080920152 hasAuthorship W2080920152A5051815364 @default.
- W2080920152 hasAuthorship W2080920152A5052894205 @default.
- W2080920152 hasAuthorship W2080920152A5060367150 @default.
- W2080920152 hasAuthorship W2080920152A5066706117 @default.
- W2080920152 hasAuthorship W2080920152A5074939684 @default.
- W2080920152 hasAuthorship W2080920152A5083356818 @default.
- W2080920152 hasAuthorship W2080920152A5090027737 @default.
- W2080920152 hasBestOaLocation W20809201522 @default.
- W2080920152 hasConcept C118552586 @default.
- W2080920152 hasConcept C121332964 @default.
- W2080920152 hasConcept C126322002 @default.
- W2080920152 hasConcept C145148216 @default.
- W2080920152 hasConcept C168563851 @default.
- W2080920152 hasConcept C207103383 @default.
- W2080920152 hasConcept C2182769 @default.
- W2080920152 hasConcept C2776174506 @default.
- W2080920152 hasConcept C2776809841 @default.
- W2080920152 hasConcept C2776999253 @default.
- W2080920152 hasConcept C2778541603 @default.
- W2080920152 hasConcept C2778609679 @default.
- W2080920152 hasConcept C2780550438 @default.
- W2080920152 hasConcept C2780733359 @default.
- W2080920152 hasConcept C2781046926 @default.
- W2080920152 hasConcept C2781089641 @default.
- W2080920152 hasConcept C44249647 @default.
- W2080920152 hasConcept C62520636 @default.
- W2080920152 hasConcept C71924100 @default.
- W2080920152 hasConceptScore W2080920152C118552586 @default.
- W2080920152 hasConceptScore W2080920152C121332964 @default.
- W2080920152 hasConceptScore W2080920152C126322002 @default.
- W2080920152 hasConceptScore W2080920152C145148216 @default.
- W2080920152 hasConceptScore W2080920152C168563851 @default.
- W2080920152 hasConceptScore W2080920152C207103383 @default.
- W2080920152 hasConceptScore W2080920152C2182769 @default.
- W2080920152 hasConceptScore W2080920152C2776174506 @default.
- W2080920152 hasConceptScore W2080920152C2776809841 @default.
- W2080920152 hasConceptScore W2080920152C2776999253 @default.
- W2080920152 hasConceptScore W2080920152C2778541603 @default.
- W2080920152 hasConceptScore W2080920152C2778609679 @default.
- W2080920152 hasConceptScore W2080920152C2780550438 @default.
- W2080920152 hasConceptScore W2080920152C2780733359 @default.
- W2080920152 hasConceptScore W2080920152C2781046926 @default.
- W2080920152 hasConceptScore W2080920152C2781089641 @default.
- W2080920152 hasConceptScore W2080920152C44249647 @default.
- W2080920152 hasConceptScore W2080920152C62520636 @default.
- W2080920152 hasConceptScore W2080920152C71924100 @default.
- W2080920152 hasIssue "4" @default.
- W2080920152 hasLocation W20809201521 @default.
- W2080920152 hasLocation W20809201522 @default.
- W2080920152 hasOpenAccess W2080920152 @default.
- W2080920152 hasPrimaryLocation W20809201521 @default.
- W2080920152 hasRelatedWork W1989185677 @default.
- W2080920152 hasRelatedWork W2032256945 @default.
- W2080920152 hasRelatedWork W2060117610 @default.
- W2080920152 hasRelatedWork W2085871520 @default.
- W2080920152 hasRelatedWork W2124044664 @default.
- W2080920152 hasRelatedWork W2327215066 @default.
- W2080920152 hasRelatedWork W2345613745 @default.
- W2080920152 hasRelatedWork W2886441505 @default.
- W2080920152 hasRelatedWork W2947444666 @default.
- W2080920152 hasRelatedWork W4304786035 @default.
- W2080920152 hasVolume "9" @default.
- W2080920152 isParatext "false" @default.
- W2080920152 isRetracted "false" @default.
- W2080920152 magId "2080920152" @default.
- W2080920152 workType "article" @default.